Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cotadutide Phase 2b in T2DM and Obesity
NCT03235050Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2017
- Primary completion
- May 2018
- Modality
- Peptides
- Countries
- 8
01
Overview
A Phase 2 trial of cotadutide in type 2 diabetes mellitus (T2DM), obesity, sponsored by AstraZeneca. Started Aug 2017; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT03235050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03235050.